Can Treg elimination enhance NK cell therapy for AML?

Blood

Volumn 123, Issue 25, 2014, Pages 3848-3849

  Rooney, Cliona M ^a,b  

^a TEXAS CHILDREN S HOSPITAL   (United States)

^b HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN; INTERLEUKIN 15; INTERLEUKIN 2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ANTINEOPLASTIC ACTIVITY; CANCER CONTROL; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CANCER PATIENT; CELL ACTIVITY; CELL SURVIVAL; CELL THERAPY; CLINICAL TRIAL (TOPIC); DISEASE FREE SURVIVAL; DRUG POTENCY; HIGH RISK PATIENT; HLA SYSTEM; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; INNATE IMMUNITY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL KILLER CELL; NOTE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; STEM CELL TRANSPLANTATION; T LYMPHOCYTE;

DIPHTHERIA TOXIN; FEMALE; HUMANS; INTERLEUKIN-2; KILLER CELLS, NATURAL; LEUKEMIA, MYELOID; MALE; RECOMBINANT FUSION PROTEINS;

EID: 84902668875     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2014-05-570291     Document Type: Note

References (5)

1. Bachanova V, Cooley S, Defor TE, et al. Clearance of acture myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion protein. Blood. 2014;123(25):3855-3863.
2. Pedroza-Pacheco I, Madrigal A, Saudemont A. Interaction between natural killer cells and regulatory T cells: perspectives for immunotherapy. Cell Mol Immunol. 2013;10(3):222-229.
3. Stern M, Passweg JR, Meyer-Monard S, et al. Preemptive immunotherapy with puri fied natural killer cells after haploidentical SCT: a prospective phase II study in two centers. Bone Marrow Transplant. 2013;48(3):433-438.
4. Iliopoulou EG, Kountourakis P, Karamouzis MV, et al. A phase I trial of adoptive transfer of allogeneic natural killer cells in patients with advanced non-small cell lung cancer. Cancer Immunol Immunother. 2010;59(12):1781-1789.
5. Miller JS, Soignier Y, Panoskaltsis-Mortari A, et al. Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer. Blood. 2005;105(8):3051-3057.